Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension
Clinical trial NCT02867813 · COMPLETED
Trial details
- NCT number
- NCT02867813
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-02
- Primary completion
- 2022-03-21
- Enrollment
- 5035
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.